IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES

被引:778
|
作者
COX, AL
SKIPPER, J
CHEN, Y
HENDERSON, RA
DARROW, TL
SHABANOWITZ, J
ENGELHARD, VH
HUNT, DF
SLINGLUFF, CL
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT SURG,CHARLOTTESVILLE,VA 22908
[2] UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22908
[3] UNIV VIRGINIA,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908
[4] UNIV VIRGINIA,BEIRNE CARTER CTR IMMUNOL RES,CHARLOTTESVILLE,VA 22908
[5] DUKE UNIV,DEPT SURG,DURHAM,NC 27710
[6] UNIV VIRGINIA,DEPT PATHOL,CHARLOTTESVILLE,VA 22908
关键词
D O I
10.1126/science.7513441
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Of several thousand peptides presented by the major histocompatibility molecule HLA-A2.1, at least nine are recognized by melanoma-specific cytotoxic T lymphocytes (CTLs). Tandem mass spectrometry was used to identify and to sequence one of these peptide epitopes. Melanoma-specific CTLs had an exceptionally high affinity for this nine-residue peptide, which reconstituted an epitope for CTL lines from each of five different melanoma patients tested. Recognition by multiple CTL lines suggests that this may be a promising candidate for use in peptide-based melanoma vaccines.
引用
收藏
页码:716 / 719
页数:4
相关论文
共 50 条
  • [1] Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytes
    Hogan, KT
    Coppola, MA
    Gatlin, CL
    Thompson, LW
    Shabanowitz, J
    Hunt, DF
    Engelhard, VH
    Slingluff, CL
    Ross, MM
    IMMUNOLOGY LETTERS, 2003, 90 (2-3) : 131 - 135
  • [2] Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes
    Ge, HL
    Wang, Y
    Wang, SJ
    Zhang, Y
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2006, 38 (02) : 110 - 118
  • [3] The optimisation of a human melanoma-specific single chain T-cell receptor for adoptive T-cell transfer
    Hauptrock, B.
    Glomski, M. T.
    Antunes, E.
    Stolle, D.
    Thomas, S.
    Romero, P.
    Uckert, W.
    Theobald, M.
    Voss, R-H
    ONKOLOGIE, 2011, 34 : 173 - 174
  • [4] MODULATION OF INVITRO AUTOLOGOUS MELANOMA-SPECIFIC CYTOTOXIC T-CELL RESPONSES BY PHORBOL DIBUTYRATE AND IONOMYCIN
    DARROW, TL
    QUINNALLEN, MA
    CROWLEY, NJ
    SEIGLER, HF
    CELLULAR IMMUNOLOGY, 1990, 125 (02) : 508 - 517
  • [5] Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells
    Nielsen, MB
    Kirkin, AF
    Loftus, D
    Nissen, MH
    Rivoltini, L
    Zeuthen, J
    Geisler, C
    Odum, N
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (04): : 405 - 411
  • [6] MELANOMA-SPECIFIC ANTIBODIES PRODUCED IN MONKEYS BY IMMUNIZATION WITH HUMAN MELANOMA CELL LINES
    METZGAR, RS
    BERGOC, PM
    MORENO, MA
    SEIGLER, HF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 50 (04) : 1065 - 1068
  • [7] Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy
    Nolte, A
    Scheffold, C
    Slotty, J
    Huenefeld, C
    Schultze, JL
    Grabbe, S
    Berdel, WE
    Kienast, J
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (03): : 257 - 269
  • [8] Cytotoxic T Lymphocyte Antigen-4 Blockade Enhances Antitumor Immunity by Stimulating Melanoma-Specific T-cell Motility
    Pentcheva-Hoang, Tsvetelina
    Simpson, Tyler R.
    Montalvo-Ortiz, Welby
    Allison, James P.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (10) : 970 - 980
  • [9] T-CELL RECEPTOR USAGE BY MELANOMA-SPECIFIC CLONAL AND HIGHLY OLIGOCLONAL TUMOR-INFILTRATING LYMPHOCYTE LINES
    SHILYANSKY, J
    NISHIMURA, MI
    YANNELLI, JR
    KAWAKAMI, Y
    JACKNIN, LS
    CHARMLEY, P
    ROSENBERG, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2829 - 2833